Table 3 Relationships between patient characteristics and colonoscopy use within 14 months of surgery (N = 1423)
From: Variation in use of surveillance colonoscopy among colorectal cancer survivors in the United States
| Â | Had colonoscopy N (%) | Bivariate | Multivariate | ||
|---|---|---|---|---|---|
| Â | Â | OR | p | OR | p |
All | 692 (49) | Â | Â | Â | Â |
Age | Â | Â | Â | Â | Â |
   <65 years | 328 (53) | 1.35 | <0.01 | 1.05 | 0.69 |
   ≥65 years | 364 (45) | 1.00 | - | 1.00 | - |
Sex | Â | Â | Â | Â | Â |
   Male | 393 (47) | 0.87 | 0.19 | 0.87 | 0.26 |
   Female | 299 (51) | 1.00 | - | 1.00 | - |
Site of tumor | Â | Â | Â | Â | Â |
   Colon | 576 (50) | 1.28 | 0.08 | 1.41 | 0.02 |
   Rectum | 116 (44) | 1.00 | - | 1.00 | - |
Stage | Â | Â | Â | Â | Â |
   I | 192 (46) | 1.00 | - | 1.00 | - |
   II | 244 (49) | 1.01 | 0.92 | 0.89 | 0.44 |
   III | 255 (50) | 1.12 | 0.30 | 0.68 | 0.04 |
Comorbidities | Â | Â | Â | Â | Â |
   None | 197 (55) | 1.00 | - | 1.00 | - |
   Mild | 330 (52) | 1.25 | 0.04 | 0.92 | 0.56 |
   Moderate | 110 (43) | 0.76 | 0.046 | 0.69 | 0.04 |
   Severe | 55 (32) | 0.45 | <0.01 | 0.44 | <0.01 |
Race/ethnicity | Â | Â | Â | Â | Â |
   Non-Hispanic White | 468 (49) | 1.00 | - | 1.00 | - |
   Non-Hispanic Black | 120 (47) | 0.91 | 0.48 | 0.89 | 0.48 |
   Hispanic | 38 (45) | 0.87 | 0.54 | 0.95 | 0.83 |
   Other | 66 (54) | 1.25 | 0.24 | 1.50 | 0.05 |
Education | Â | Â | Â | Â | Â |
   <high school | 328 (46) | 1.00 | - | 1.00 | - |
   ≥High school | 364 (51) | 1.22 | 0.07 | 1.07 | 0.62 |
Annual income | Â | Â | Â | Â | Â |
   <$50,000 | 364 (44) | 0.66 | <0.01 | 0.74 | 0.05 |
   ≥$50,000 | 328 (55) | 1.00 | - | 1.00 | - |
Marital status | Â | Â | Â | Â | Â |
   Married | 415 (51) | 1.20 | 0.09 | 1.03 | 0.79 |
   Not married | 277 (46) | 1.00 | - | 1.00 | - |
Site of care | Â | Â | Â | Â | Â |
   Alabama | 156 (51) | 1.13 | 0.35 | 1.92 | <0.01 |
   Los Angeles | 144 (48) | 0.97 | 0.81 | 1.49 | 0.03 |
   North Carolina | 236 (57) | 1.58 | 0.00 | 2.32 | <0.01 |
   VA hospitals | 66 (40) | 0.67 | 0.02 | 1.38 | 0.16 |
   Managed care | 90 (38) | 1.00 | - | 1.00 | - |
Saw a primary care provider | Â | Â | Â | Â | Â |
   Yes | 440 (51) | 1.22 | 0.06 | 1.44 | <0.01 |
   No | 252 (46) | 1.00 | - | 1.00 | - |
Saw a medical oncologist | Â | Â | Â | Â | Â |
   Yes | 530 (51) | 1.49 | <0.01 | 1.23 | 0.17 |
   No | 162 (41) | 1.00 | - | 1.00 | - |
Had adjuvant chemotherapy | Â | Â | Â | Â | Â |
   Yes | 332 (56) | 1.69 | <0.01 | 1.75 | <0.01 |
   No | 360 (43) | 1.00 | - | 1.00 | - |